An interventional study of micro osteoperforation in Pain and Rate of Canine Retraction, sponsored by Foundation University Islamabad. Completed at 1 site in Pakistan. Open to participants aged 14 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-27.
Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Supportive care
DEFINITION: A short description of clinical study , including a brief statement of clinical study's hypothesis, written in language intended for the lay public Limit: 5000 CHARACTERS
Definition: Extended description of the protocol ,including more technical information(as compared to the brief Summary), if desired. Do not include the entire protocol; do not duplicate information recorded in other data elements, such as eligibility criteria or outcome measures.
Limit:32,000 characters. For Patient Registries: Also describe the applicable registry procedures and other quality factors (for examples, third party certification, on site audit). In particular , summarize any procedures implemented as part of the patient registry, including , but not limited to the following:
Foundation University Islamabad is the lead sponsor of 238 studies on the registry; 128 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Smoker
-
Participants in this arm will receive no MOP treatment
participants in this arm will receive MOPS intervention
Other: micro osteoperforation
one side used for mops while other side will be control in same patient
Also known as: Placebo/Controlled
pain will be measured after intervention of visual analogue scale
patient after undergoing micro-osteoperforation will be aske to measure pain and check rate of canine retraction
Time frame: three months since the MOPS
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Foundation University Islamabad